Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloperidone for Acute Manic or Mixed Episodes in Bipolar I Disorder
NCT04819776Phase 3Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Mar 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of iloperidone in bipolar I disorder, sponsored by Vanda Pharmaceuticals Inc.. Started Mar 2021; status: completed.
02
Drugs
iloperidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT04819776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04819776.